Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system. Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity to the protein networks implicated in neurodegeneration and parkinsonism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar phenotype has also been described in the context of loss‐of‐function mutations in the P‐type ATPase gene ATP13A2, in which recessive, early‐onset PD has been linked to defective acidification of lysosomes and insufficient autophagy (Ramirez et al, 2006).”
From Autophagy in major human diseases (2021) · cites this paper as Ramirez et al, 2006
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“By mutation screening or linkage analysis, we excluded the known autosomal recessive Parkinson disease genes and loci: PARK2 (also known as Parkin ; ref”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Evolution of Substrate Specificities in the P-Type ATPase Superfamily
Axelsen, K. B., & Palmgren, M. G. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00006286 · Cited by 910
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Cited by
Items 801–900 of 1,000
Genetic mimics of the non-genetic atypical parkinsonian disorders – the ‘atypical’ atypical
Giagkou, N., Bhatia, K. P., Höglinger, G. U., & Stamelou, M. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.008 · Cited by 11
Decreased Expression of Lysosomal Alpha-Galactosiase A Gene in Sporadic Parkinson’s Disease
Wu, G., Huang, J. A., Feng, X., Zhang, A., Li, J., Pang, S., Gu, K., Dong, H., Zhang, J., Gao, H., et al. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0516-0 · Cited by 11
Pallidopyramidal disease: A misnomer?
Horstink, M. W. I. M., Dekker, M. C. J., Montagna, P., Bonifati, V., & van de Warrenburg, B. P. C. (2010) · Movement Disorders · doi:10.1002/mds.23118 · Cited by 11
Lysosomal Storage Disorders and Iron
Brás, J. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-410502-7.00012-0 · Cited by 11
Yoon, L., Botham, R. C., Verhelle, A., Wu, Y., Cole, C. M., Tan, E. P., Massey, L. A., Sanz-Martinez, P., Chou, C., Xu, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.29.509997 · Cited by 15
Hermey, G., & Klein, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.361544 · Cited by 10
“…or compound heterozygous mutations in ATP13A2 (CLN12) cause the Kufor-Rakeb syndrome, a rare autosomal recessive form of juvenile-onset atypical PD (PARK9) (Ramirez et al., 2006) and biallelic mutations in ATP13A2 underlie autosomal recessive spastic paraplegia 78 (Estrada-Cuzcano et al., 2017).”
BackgroundInfluentialiSCORE-PD: an isogenic stem cell collection to research Parkinson’s disease
Busquets, O., Li, H., Syed, K. M., Jerez, P. Á., Dunnack, J., Bu, R. L., Verma, Y., Pangilinan, G. R., Martin, A., Straub, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74355-8 · Cited by 10
Genetics of Parkinson´s disease: Recessive forms
Salles, P. A., Pizarro-Correa, X., & Chaná‐Cuevas, P. (2024) · Neurology Perspectives · doi:10.1016/j.neurop.2024.100147 · Cited by 10
Autophagy Dysfunction and Neurodegeneration: Where Does It Go Wrong?
Oettinger, D., & Yamamoto, A. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169219 · Cited by 11
Asthana, J., & Shravage, B. V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.986849 · Cited by 10
Altered apoptosis regulation in Kufor–Rakeb syndrome patients with mutations in the ATP13A2 gene
Radi, E., Formichi, P., Maio, G. D., Battisti, C., & Federico, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01488.x · Cited by 10
Duda, J., Fauler, M., Gründemann, J., & Liss, B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7558-7_19 · Cited by 10
Self-citationUgolino, J., Dziki, K. M., Kim, A., Wu, J. J., Vogel, B. E., & Monteiro, M. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220849 · Cited by 11
Ca2+ signalling: A common language for organelles crosstalk in Parkinson's disease
Peggion, C., Barazzuol, L., Poggio, E., Calí, T., & Brini, M. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102783 · Cited by 11
[Genetic factors associated with dementia in Parkinson's disease (PD)].
Romo-Gutiérrez, D., Yescas, P., López, M., & Boll, M. (2015) · PubMed · Cited by 10
Follow-up study of variants of the GIGYF2 gene in Chinese patients with Parkinson’s disease
Wang, L., Guo, J., Zhang, W., Xu, Q., Zuo, X., Shi, C., Luo, L.-Z., Liu, J., Hu, L., Hu, Y., et al. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.05.014 · Cited by 10
Coffee, Genetic Variants, and Parkinson's Disease: Gene–Environment Interactions
Yamada-Fowler, N., & Söderkvist, P. (2015) · Journal of Caffeine Research · doi:10.1089/jcr.2014.0028 · Cited by 10
Sowada, N., Stiller, B., & Kubisch, C. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.157 · Cited by 10
Self-citationAnimal models of Parkinson's disease and their applications
Lee, M. K., Park, H. J., & Zhao, T. (2016) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s85419 · Cited by 10
Connecting Ca2+ and Lysosomes to Parkinson Disease
Kilpatrick, B. S. (2016) · Messenger · doi:10.1166/msr.2016.1059 · Cited by 14
Nosology and Phenomenology of Psychosis in Movement Disorders
Rossi, M., Farcy, N., STARKSTEIN, S. E., & Merello, M. (2019) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12882 · Cited by 11
Clinical overview and phenomenology of movement disorders
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00001-9 · Cited by 16
Mochizuki, H. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70012-4 · Cited by 10
Generative modeling for RNA splicing prediction and designPreprint
Wu, D., Maus, N., Jha, A., Yang, K., Wales-McGrath, B. D., Jewell, S., Tangiyan, A., Choi, P. S., Gardner, J. R., & Barash, Y. (2026) · eLife · doi:10.7554/elife.106043 · Cited by 10
Neuronal Vulnerability to Degeneration in Parkinson’s Disease and Therapeutic Approaches
Sharma, T., Kumar, R., & Mukherjee, S. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230426155432 · Cited by 9
Bonavita, R., Vitale, F., Verdicchio, L. V., Williams, S. V., Caporaso, M. G., Fleming, A., & Renna, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1538377 · Cited by 9
Verma, A. K., Funahashi, Y., Roy, B., & Dwivedi, Y. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118452 · Cited by 9
Characterizing the Expression Patterns of Parkinson’s Disease Associated Genes
Li, B., Zhao, G., Li, K., Wang, Z., Fang, Z., Wang, X., Luo, T., Zhang, Y., Wang, Y., Chen, Q., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.629156 · Cited by 11
Chen, K., Padilla, C. G., Kiselyov, K. I., & Kozai, T. D. Y. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122316 · Cited by 9
Fujita, M., Sekigawa, A., Sekiyama, K., Sugama, S., & Hashimoto, M. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5246-8 · Cited by 11
Biomarkers for the diagnosis and management of Parkinson's disease
Waragai, M., Sekiyama, K., Fujita, M., Tokuda, T., & Hashimoto, M. (2012) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2013.733694 · Cited by 11
Regulation of membrane dynamics by Parkinson’s disease-associated genes
Inoshita, T., Cui, C., Hattori, N., & Imai, Y. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0959-z · Cited by 11
Fearing, B. V., Speer, J. E., Jing, L., Kalathil, A., Kelly, M. P., Buchowski, J. M., Zebala, L. P., Luhmann, S. J., Gupta, M. C., & Setton, L. A. (2020) · JOR Spine · doi:10.1002/jsp2.1111 · Cited by 11
Ratti, A., Peverelli, S., D’Adda, E., Colombrita, C., Gennuso, M., Prelle, A. C., & Silani, V. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1962355 · Cited by 9
Progress in Parkinson's disease animal models of genetic defects: Characteristics and application
Zhang, C., Chen, S., Li, X., Xu, Q., Lin, Y., Lin, F., Yuan, M., Zi, Y., & Cai, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113768 · Cited by 9
The Neurogenetics of Parkinson’s Disease and Putative Links to Other Neurodegenerative Disorders
Lill, C. M., & Klein, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00001-8 · Cited by 10
Shaw, C. A. (2017) · Wiley eBooks · doi:10.1002/9781118634523.refs · Cited by 10
Genetically encoded fluorescent sensors for visualizing polyamine levels, uptake, and distributionPreprint
Tamura, R., Chen, J., Jaeger, M. D., Morris, J. F., Scott, D. A., Vangheluwe, P., & Looger, L. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.21.609037 · Cited by 10
Impaired pre-synaptic plasticity and visual responses in auxilin-knockout mice
Cheng, X., Tang, Y. J., Vidyadhara, D. J., Li, B., Zimmerman, M., Pak, A., Nareddula, S., Edens, P. A., Chandra, S. S., & Chubykin, A. A. (2023) · iScience · doi:10.1016/j.isci.2023.107842 · Cited by 8
A Review of the Recent Advances in the Pharmacological Management of Parkinson’s Disease
Li, A., Cha, A., Huang, M. Z., Dhami, S., & Pemminati, S. (2025) · Cureus · doi:10.7759/cureus.93123 · Cited by 12
Phenotypic characterization of an Atp13a2 knockout rat model of Parkinson’s disease
Kinet, R., Sikora, J., Arotçarena, M.-L., Decourt, M., Balado, É., Doudnikoff, É., Bohic, S., Vesnaver, M., Lovisotto, A., Thiolat, M.-L., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01171-0 · Cited by 8
Bae, E.-J., Lee, C.-S., Lee, H.-J., Kim, S., & Lee, S. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.365 · Cited by 8
Rodent models based on endolysosomal genes involved in Parkinson's disease
Sanchiz-Calvo, M., Bentea, E., & Baekelandt, V. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.09.004 · Cited by 8
Autophagic signatures in peripheral blood mononuclear cells from Parkinson's disease patients
Lee, M. S., Kim, J. W., Park, D. G., Heo, H., Kim, J., Yoon, J. H., & Chang, J. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100173 · Cited by 9
Motor pathway excitability in ATP13A2 mutation carriers: A transcranial magnetic stimulation study
Zittel, S., Kroeger, J., van der Vegt, J. P. M., Siebner, H. R., Brüggemann, N., Ramírez, A., Behrens, M. I., Gerloff, C. P., Bäumer, T., Klein, C., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.10.020 · Cited by 8
Self-citationPathways of protein synthesis and degradation in PD pathogenesis
Langston, R. G., & Cookson, M. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.01.002 · Cited by 9
Polyamine Transport Assay Using Reconstituted Yeast Membranes
van Veen, S., Martin, S., Schuermans, M., & Vangheluwe, P. (2021) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3888 · Cited by 8
Iron Metabolism and Related Disorders
Hoda, K., Bowlus, C. L., Chu, T. W., & Gruen, J. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00106-3 · Cited by 8
Pesticides and Parkinson’s Disease
Arthur, G., & Jeff, M. (2011) · InTech eBooks · doi:10.5772/16479 · Cited by 8
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 9
Mechanisms Implicated in Parkinson Disease from Genetic Perspective
Popescu, C. (2016) · Medical & Clinical Reviews · doi:10.21767/2471-299x.1000028 · Cited by 8
Yao, M.-L., Zhang, H., Xu, Y., Zhang, S., Gao, Y.-Z., Shu, M., & Zhang, J. (2019) · Current Medical Science · doi:10.1007/s11596-019-2009-3 · Cited by 8
pink1, atp13a2 and uchl1 expressions are affected by inflammation in the brain
Moriya, S., Tan, V. P. Y., Yee, A. K., & Parhar, I. S. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134330 · Cited by 10
Miranda, M., Harmuth, F., Bustamante, M. L., Rossi, M., Sturm, M., Magnússon, Ó. Þ., Bauer, P., Klockgether, T., & Ramírez, A. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.10.004 · Cited by 8
ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson's disease
Fernández‐Espejo, E., de Fonseca, F. R., Suárez, J., González-Aparicio, R., & Santurtún, A. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.05.014 · Cited by 8
Polyglucosan Bodies in Aged Brain and Neurodegeneration: Cause or Consequence?
Rai, A., & Ganesh, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-3585-3_4 · Cited by 11
Extracellular vesicles in neurodegenerative disorders
Mäger, I., Willms, E., Bonner, S. E., Hill, A. F., & Wood, M. J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816053-4.00012-2 · Cited by 8
New wine in old bottles: current progress on P5 ATPases
Huang, Z., Feng, Z., & Zou, Y. (2021) · FEBS Journal · doi:10.1111/febs.16172 · Cited by 8
Phenotype Differences Between ATP13A2 Heterozygous and Knockout Mice Across Aging
Croucher, K. M., Lepp, J., Bechtold, J., Hamad, E. J., Scott, S., Bittner, C., Rogers, S., Ong, C., Boehme, S., Wang, Z., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157030 · Cited by 7
The quest for Parkinson’s disease biomarkers: traditional and emerging multi-omics approaches
Sharma, P., & Dhamija, R. K. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10929-x · Cited by 7
Two lysosomal genes ATP13A2 and GBA1 interact to drive neurodegeneration
Gu, M., Zhao, J., Deng, M., Lin, G., Pan, X., Lin, W. W., Ma, M., Kim, J., Byeon, S. K., Pandey, A., et al. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00923-z · Cited by 7
Sources of Oxidative Stress in Parkinson’s Disease: Pathways and Therapeutic Implications
Yordanov, Y., Stefanova, D., Kondeva-Burdina, M., & Tzankova, V. (2026) · Antioxidants · doi:10.3390/antiox15020187 · Cited by 8
Abubakar, M., Alom, S., Ali, F., Ali, S. R., Adhikary, K., Sarika, S., Gupta, P. K., Puppala, E. R., Murti, K., Nand, S., et al. (2026) · Current Neuropharmacology · doi:10.2174/011570159x446831260303200516 · Cited by 9
Mitochondrial dysfunction, iron accumulation, and ferroptosis in Parkinson’s disease
Teferi, N., Challa, M., Woodiwiss, T. R., Allen, B. G., & Petronek, M. S. (2023) · Redox Experimental Medicine · doi:10.1530/rem-23-0004 · Cited by 8
Kaushik, A. C., Mehmood, A., Wei, D., Nawab, S., Sahi, S., & Kumar, A. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166037 · Cited by 8
Tsunemi, T., Ishiguro, Y., Yoroisaka, A., Feng, D., Shimada, T., Niiyama, S., Sasazawa, Y., Ishikawa, K., Akamatsu, W., & Hattori, N. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.2350-23.2024 · Cited by 7
Gene-modified animal models of Parkinson's disease
Peng, Y., Jiang, D., Yao, S., Zhang, X., Sugimoto, K., Liu, J. –., Du, M., Lin, L.-Y., Chen, Q., & Hong, J. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115287 · Cited by 7
Kufor Rakeb syndrome without gaze palsy and pyramidal signs due to novel ATP13A2 mutations
Satolli, S., Fonzo, A. D., Zanobio, M., Pezzullo, G., & Micco, R. D. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06899-2 · Cited by 7
Fishman-Jacob, T., & Youdim, M. B. H. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02687-6 · Cited by 7
Protein modification regulated autophagy in Bombyx mori and Drosophila melanogaster
Wu, W., Lin, L., Zhao, Y., Li, H., & Zhang, R. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1281555 · Cited by 7
Neurodegeneration in Parkinson’s Disease: Genetics Enlightens Physiopathology
Corti, O., Fournier, M., & Brice, A. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_17 · Cited by 7
SPECT Molecular Imaging in Familial Parkinson's Disease
Varrone, A., & Pellecchia, M. T. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.09.004 · Cited by 7
No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients
Li, L., Funayama, M., Tomiyama, H., Li, Y., Yoshino, H., Sasaki, R., Kokubo, Y., Kuzuhara, S., Mizuno, Y., & Hattori, N. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.071 · Cited by 7
Inhibition of the Formation of the Spf1p Phosphoenzyme by Ca2+
Corradi, G. R., Czysezon, N. A., Mazzitelli, L. R., Sarbia, N., & Adamo, H. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.695122 · Cited by 7
DNAJC6 mutations are not common causes of early onset Parkinson’s disease in Chinese Han population
Shi, C., Fang, L., Yang, J., Zhang, S., Mao, C., Wang, H., Shi, M., Liu, Y., Song, B., & Xu, Y. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.09.044 · Cited by 7
Kufor‐Rakeb Syndrome Due to a Novel ATP 13A2 Mutation in 2 Chinese‐American Brothers
Noch, E., Henchcliffe, C., Hellmers, N., Chu, M. L., Pappas, J., Moran, E. S., Alcaraz, W. A., & Sarva, H. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12567 · Cited by 7
Sun, A., Chang, I. J., Lam, C. T., & Berry, G. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-812535-9.00014-5 · Cited by 12
Molecular Pathogenesis, Experimental Models and New Therapeutic Strategies for Parkinson‘s Disease
Yamashita, H., & Matsumoto, M. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.4.447 · Cited by 8
Sanchiz-Calvo, M., Coccia, E., Cawthorne, C., Parfitt, G. M., Torre-Muruzabal, T., Tsafaras, G., Laere, K. V., Cabezudo, D., Cascalho, A. C. C., den Haute, C. V., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02908-0 · Cited by 6
The interplay between autophagy and unconventional secretion in neurodegeneration
Renna, M., Bonavita, R., Dixon, G., Verdicchio, L. V., & Fleming, A. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2025.12.007 · Cited by 7
Rudenok, M. M., Alieva, A. K., Nikolaev, M. A., Kolacheva, A. A., Ugryumov, M. V., Пчелина, С. Н., Slominsky, P. A., & Shadrina, M. I. (2019) · Molecular Biology · doi:10.1134/s002689331901014x · Cited by 6
Genetic Models of Parkinson’s Disease
Kachidian, P., & Gubellini, P. (2020) · Neuromethods · doi:10.1007/978-1-0716-0912-5_3 · Cited by 7
The conserved cellular roles of CLN proteins: Novel insights from Dictyostelium discoideum
Remtulla, A. A. N., & Huber, R. J. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151305 · Cited by 6
Eswari, S., & Mishra, A. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273336139241211071748 · Cited by 6
Role of Epigenetics in Neural Differentiation: Implications for Health and Disease
Toraño, E. G., Fernández, A. F., Urdinguio, R. G., & Fraga, M. F. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0706-9_2 · Cited by 7
Yang, X. (2014) · Medical Science Monitor · doi:10.12659/msm.892821 · Cited by 6
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Zheng, K., & Li, T. (2021) · Immunogenetics · doi:10.1007/s00251-021-01216-7 · Cited by 6
Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00003-3 · Cited by 10
Dystonic Opisthotonus in Kufor-Rakeb Syndrome: Expanding the Phenotypic and Genotypic Spectrum
Gurram, S., Holla, V. V., Kumari, R., Dhar, D., Kamble, N. L., Yadav, R., Muthusamy, B., & Pal, P. K. (2023) · Journal of Movement Disorders · doi:10.14802/jmd.23098 · Cited by 6
The Use of Biomarkers for Prediction and Prevention of Alzheimer’s and Parkinson’s Diseases
Mandel, S. A., & Korczyn, A. D. (2012) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5866-7_6 · Cited by 7
The KM-parkin-DB: A Sub-setMutationViewDatabase Specialized forPARK2(PARKIN) Variants
Mitsuyama, S., Ohtsubo, M., Minoshima, S., & Shimizu, N. (2015) · Human Mutation · doi:10.1002/humu.22803 · Cited by 6
Lohmann, K., & Klein, C. (2008) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000275627.47561.c3 · Cited by 6
Abnormal Function of Metalloproteins Underlies Most Neurodegenerative Diseases
Kanninen, K. M., & White, A. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00021-x · Cited by 6
Ocular Manifestations of Neuronal Ceroid Lipofuscinoses
Singh, R. B., Gupta, P., Kartik, A., Farooqui, N., Singhal, S., Shergill, S., Singh, K. P., & Agarwal, A. K. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1936571 · Cited by 7
Movement Disorders and Inherited Metabolic Disorders: Recognition, Understanding, Improving Outcomes
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108556767 · Cited by 10
Clinical overview and phenomenology of movement disorders
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00001-9 · Cited by 7
Animal Models of Parkinson's Disease to Aid Drug Discovery and Development
Merchant, K., Chesselet, M.-F., Hu, S., & Fahn, S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00017-5 · Cited by 6
Asmi, S., Krishnan, A., Alexander, S. M., Ameer, J. M., Nidhish, T., Sreetama, S. C., Tr, K., Shenoi, R. A., Chakravarthy, S. G. S., & Chandra, G. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103070 · Cited by 6
Puthusseri, S. P., Ravivarma, S., Johny, M., & Vengellur, A. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01187-x · Cited by 6
Metadata
- Authors
- Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I., & Kubisch, C.
- Affiliations
- University of Cologne (DE)
- Philipps University of Marburg (DE)
- University of Leeds (GB)
- Centro de Estudios Científicos (CL)
- University of Bonn (DE)
- King Hussein Medical Center (JO)
- Pinderfields Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Kubisch, Christian
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-09-10
- Volume
- 38
- Issue
- 10
- Pages
- 1184-1191
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2139369185
- Cited by
- 1,208
- References
- 30
- Citations by year
- 2026: 42 · 2025: 44 · 2024: 39 · 2023: 49 · 2022: 45 · 2021: 70 · 2020: 73 · 2019: 69 · 2018: 54 · 2017: 64 · 2016: 76 · 2015: 59 · 2014: 57 · 2013: 71 · 2012: 64
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion)
- Funders
- Tinker Foundation
- Wellcome Trust
- Royal Society
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Rheinische Friedrich-Wilhelms-Universität Bonn
- National Institutes of Health
- Directorate for Biological Sciences
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- ATP13A2, P-type ATPase, Kufor-Rakeb syndrome, PARK9, autosomal recessive inheritance, loss-of-function mutations, neurodegeneration, endoplasmic reticulum retention, proteasomal degradation, protein misfolding
- MeSH terms
- Adenosine Triphosphatases, Dementia, Endoplasmic Reticulum, Female, Proton-Translocating ATPases, Humans, Lysosomes, Male, Mesencephalon, Mutation, Neurons, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.